financetom
Business
financetom
/
Business
/
Jefferies Financial Shares Are Trading Higher Friday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jefferies Financial Shares Are Trading Higher Friday: What's Going On?
Oct 17, 2025 11:30 AM

Jefferies Financial Group, Inc. ( JEF ) shares are trading higher Friday following reports suggesting that its fund connected to First Brands is separate from its investment banking business

What To Know: According to Reuters, Jefferies executives said at the bank's investor day that the Point Bonita fund involved in the collapse of auto parts maker First Brands operates independently from its investment banking division.

"The Point Bonita fund in asset management sits absolutely separate, distinct and apart from whatever happens in investment banking. Kind of Chinese Wall 101," said President Brian Friedman. He added that the fund's 2019 decision to engage with First Brands was made independently from the investment banking side.

CEO Rich Handler said Jefferies believes it "was defrauded" in the situation but noted that the overall environment remains "generally good."

Jefferies previously said its exposure to First Brands is limited and any potential loss would be "readily absorbable."

Related Link: American Express Lifts 2025 Outlook After Double-Digit Revenue Growth, Strong Consumer Spending

JEF Price Action: At the time of writing, Jefferies Financial ( JEF ) stock is trading 5.06% higher at $51.27, according to data from Benzinga Pro.

This illustration was generated using artificial intelligence via Midjourney.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Why Is Apogee Therapeutics Stock Trading Higher On Monday?
Why Is Apogee Therapeutics Stock Trading Higher On Monday?
May 26, 2025
Apogee Therapeutics, Inc. ( APGE ) on Monday revealed interim data from its Phase 1b trial of APG808, a novel half-life extended IL-4Rα antibody, in patients with mild-to-moderate asthma. The Phase 1b double-blind, placebo-controlled, multiple-dose trial evaluated the safety and tolerability of APG808 in 22 adult patients with mild-to-moderate asthma. The trial also evaluated fractional exhaled nitric oxide concentration (FeNO),...
BYD factory delayed in Brazil to be 'fully functional' by end-2026, says official
BYD factory delayed in Brazil to be 'fully functional' by end-2026, says official
May 26, 2025
RIO DE JANEIRO (Reuters) -Chinese electric car maker BYD's new factory in Brazil will be fully functional by December 2026, after its operations were delayed because of an investigation into labor abuses, Bahia state labor secretary Augusto Vasconcelos said in a video on Monday. By the end of this year, the factory should start producing cars from semi-finished kits, he...
Medicus Pharma's 'Savvy' Antev Deal De-Risks Pipeline Expansion, Enhances Near-Commercial Portfolio
Medicus Pharma's 'Savvy' Antev Deal De-Risks Pipeline Expansion, Enhances Near-Commercial Portfolio
May 26, 2025
In April, Medicus Pharma Ltd. ( MDCX ) agreed to acquire all of Antev’s issued and outstanding shares on a share exchange. Antev is a clinical-stage biotech company developing Teverelix, a next-generation GnRH antagonist, as the first in-market product for cardiovascular high-risk prostate cancer patients and patients with first acute urinary retention (AURr) episodes due to an enlarged prostate. Medicus...
Copyright 2023-2026 - www.financetom.com All Rights Reserved